ePMA is challenging - it is used by three professional groups with different demands and expectations, which to be successful means that the Trusts must have clinical buy-in and leadership (Ann Slee, Associate Chief Clinical Information Officer, Medicines at NHSx).

Get an exclusive insight into what more than 40 ePMA key stakeholders - CCIOs, CNIOs, Chief Medical Officers, Lead Pharmacists, ePMA Project Leads - established and concluded at the 2019 OPENeP Community day. There, they discussed topics related to the ePMA journey from tender to roll-out - the benefits of ePMA, its obstacles and expectations.

In the document, you will find:

a) summaries of four exclusive lectures by:
  • Ann Slee, Associate Chief Clinical Information Officer (Medicines) at NHSx: It is essential to configure the system beyond just the implementation period.
  • Dr Gorazd Kalan, former Director of the Paediatric Intensive Care Unit at EMRAM 6 Stage University Children's Hospital Ljubljana: Clinicians shouldn’t be at the centre of implementation due to their time restrictions.
  • Gemma Chappell and Simon Needham, Digital Project Leads at Taunton Somerset NHS Foundation Trust: Choose the key persons for the project: they have to be respected, well connected and experts in their fields.
  • Duncan Cripps, Lead Pharmacist for e-prescribing system implementation at the University Hospitals Plymouth NHS Trust: Include non-clinical staff earlier to unburden the clinical team during the implementation process.
b) workshop outcomes, where 42 key ePMA stakeholders were asked to think and discuss:
  • What are the vital value-based metrics that you hope to achieve by implementing ePMA?
  • What do you see as the key obstacles in achieving those metrics?
  • What would be the most important values and KPI’s when it comes to the vendor of choice?